-
My Account
My Account
BSE Live
Mar 05, 16:00Prev. Close
914.90
Open Price
914.90
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Mar 05, 15:58Prev. Close
919.00
Open Price
917.80
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Half Yearly Results of Thyrocare Technologies (in Rs. Cr.) | Sep '20 | Mar '20 | Sep '19 | Mar '19 | Sep '18 | |
| Net Sales/Income from operations | 202.94 | 191.61 | 208.39 | 185.41 | 184.87 | |
| Other Operating Income | -- | -- | -- | -- | -- | |
| Total Income From Operations | 202.94 | 191.61 | 208.39 | 185.41 | 184.87 | |
| EXPENDITURE | ||||||
| Consumption of Raw Materials | 75.17 | 51.81 | 58.36 | 52.43 | 50.82 | |
| Purchase of Traded Goods | 1.01 | 1.27 | 0.98 | 0.89 | 1.44 | |
| Increase/Decrease in Stocks | -0.42 | -0.26 | 0.17 | 0.24 | -0.50 | |
| Power & Fuel | -- | -- | -- | -- | -- | |
| Employees Cost | 21.75 | 24.50 | 21.25 | 23.04 | 17.47 | |
| Depreciation | 9.72 | 10.27 | 9.27 | 7.79 | 6.68 | |
| Excise Duty | -- | -- | -- | -- | -- | |
| Admin. And Selling Expenses | -- | -- | -- | -- | -- | |
| R & D Expenses | -- | -- | -- | -- | -- | |
| Provisions And Contingencies | -- | -- | -- | -- | -- | |
| Exp. Capitalised | -- | -- | -- | -- | -- | |
| Other Expenses | 34.24 | 42.30 | 32.89 | 40.71 | 35.60 | |
| P/L Before Other | 61.47 | 61.72 | 85.47 | 60.31 | 73.36 | |
| Other Income | 6.85 | 3.77 | 6.71 | 7.43 | 6.23 | |
| P/L Before Int. | 68.32 | 65.49 | 92.18 | 67.74 | 79.59 | |
| Interest | 0.42 | 0.53 | 0.79 | 0.24 | 0.23 | |
| P/L Before Exceptional Items & Tax | 67.90 | 64.96 | 91.39 | 67.50 | 79.36 | |
| Exceptional Items | -- | -44.33 | -- | -- | -- | |
| P/L Before Tax | 67.90 | 20.63 | 91.39 | 67.50 | 79.36 | |
| Tax | 17.71 | 8.81 | 23.86 | 24.17 | 27.46 | |
| P/L After Tax from Ordinary Activities | 50.19 | 11.82 | 67.53 | 43.33 | 51.90 | |
| Prior Year Adjustments | -- | -- | -- | -- | -- | |
| Extra Ordinary Items | -- | -- | -- | -- | -- | |
| Net Profit/(Loss) For the Period | 50.19 | 11.82 | 67.53 | 43.33 | 51.90 | |
| Equity Share Capital | 52.84 | 52.84 | 52.80 | 52.80 | 53.59 | |
| Reserves Excluding Revaluation Reserves | -- | -- | -- | -- | -- | |
| Equity Dividend Rate (%) | -- | -- | -- | -- | -- | |
| EPS Before Extra Ordinary | ||||||
| Basic EPS | 9.51 | 2.24 | 12.79 | -- | 9.66 | |
| Diluted EPS | 9.48 | -- | 12.79 | -- | 9.64 | |
| EPS After Extra Ordinary | ||||||
| Basic EPS. | 9.51 | 2.24 | 12.79 | -- | 9.66 | |
| Diluted EPS. | 9.48 | -- | 12.79 | -- | 9.64 | |
| Public Share Holding | ||||||
| No Of Shares (Crores) | -- | -- | -- | -- | -- | |
| Share Holding (%) | -- | -- | -- | -- | -- | |
| Promoters and Promoter Group Shareholding | ||||||
| a) Pledged/Encumbered | ||||||
| - Number of shares (Crores) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- | |
| b) Non-encumbered | ||||||
| - Number of shares (Crores). | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group). | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company). | -- | -- | -- | -- | -- |
02.02.2021
Thyrocare Techn Standalone December 2020 Net Sales at Rs 132.17 crore, up 34.88% Y-o-Y
02.11.2020
Thyrocare Techn Standalone September 2020 Net Sales at Rs 148.54 crore, up 37.68% Y-o-Y
30.10.2020
Thyrocare Techn Standalone September 2020 Net Sales at Rs 148.54 crore, up 37.68% Y-o-Y
08.08.2020
Sell Thyrocare Technologies; target of Rs 307: Prabhudas Lilladher
02.02.2021
Thyrocare Techn Standalone December 2020 Net Sales at Rs 132.17 crore, up 34.88% Y-o-Y
02.11.2020
Thyrocare Techn Standalone September 2020 Net Sales at Rs 148.54 crore, up 37.68% Y-o-Y
30.10.2020
Thyrocare Techn Standalone September 2020 Net Sales at Rs 148.54 crore, up 37.68% Y-o-Y
03.08.2020
Thyrocare Techn Standalone June 2020 Net Sales at Rs 54.40 crore, down 45.87% Y-o-Y
